Search results
MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot
Shares of Moderna MRNA rose about 4% on Friday after the company announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization to


